Stratos Wealth Partners’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$518K	Buy	350,000 +3,600	+1%	+$5.33K	0.01%	915
2025 Q1	$887K	Buy	346,400 +76,400	+28%	+$196K	0.01%	708
2024 Q4	$508K	Hold	270,000	–	–	0.01%	930
2024 Q3	$275K	Buy	+270,000	New	+$275K	﹤0.01%	1189